A growing number of women are being diagnosed with a form of breast cancer linked to breast implants, and the calls for lawsuits and legislative action or regulation are rising.
16 deaths may already be associated with the condition known as BIA-ALCL or breast-implant associated anaplastic large cell lymphoma. U.S. diagnoses of the cancer are now up to 457 from a previous high of 414. ...
continue reading...
The long-term safety of breast implants; a topic widely thought to have been resolved over the decades, is receiving renewed interest from medical communities around the world and is now on the radar of the U.S. Food and Drug Administration. What started as concern over a type of cancer predominantly tied to textured breast implants has led to new questions being ...
French health regulators have officially suspended their approval of the use of textured breast implants. The move means that the implants, which differ from the smooth-surfaced implants more widely used throughout the United States, are effectively no longer available anywhere in Europe.
Textured breast implants have been implicated as a possible cause of a specific type of lymphoma. The disease, formally known as breast implant-associated anaplastic large-cell lymphoma, ...
continue reading...The Food and Drug Administration has agreed to hold a public meeting on breast implant safety while simultaneously saying that it does not agree with claims that the implants may be dangerous.
Led by Dr. Mark Clemens, researchers at the MD Anderson Cancer Center at the University of Texas had previously focused on the risks of an exceedingly rare kind of cancer of the immune system known ...
continue reading...What a difference seven years can make.
The FDA first mentioned a possible link between rough-textured breast implants and a particular type of lymphoma in 2011. The warning was more of a glancing blow than anything and failed to raise any significant alarms – after all, the risk of breast implant-associated anaplastic large-cell lymphoma was purported to be less than one in 500,000. As one implant manufacturer chided, “A woman is ...
continue reading...The FDA issued its first warning about a possible link between textured breast implants and an exceedingly rare type of breast cancer known as anaplastic large cell lymphoma, or ALCL, in 2011. Now, some six years later, dangerously little remains known about the disease.
At this time, the exact number of cases of ALCL is extremely difficult to determine because of a lack of data ...
continue reading...
